Ausgabe 7/2005
Inhalt (9 Artikel)
Current Opinion
Discounting health effects in pharmacoeconomic evaluations
J. M. Bos, Maarten J. Postma, Lieven Annemans
Current Opinion
Price differentiation and transparency in the global pharmaceutical marketplace
David B. Ridley
Review Article
Evaluating health-related quality-of-life studies in paediatric populations
Mirella De Civita, Dean Regier, Abul H. Alamgir, Aslam H. Anis, Mark J. FitzGerald, Carlo A. Marra
Review Article
The state of patient-reported outcomes in atrial fibrillation
Karin Coyne, Mary Kay Margolis, Susan Grandy, Peter Zimetbaum
Review Article
Introducing economic evaluation as a policy tool in Korea: Will decision makers get quality information?
Kun-Sei Lee, Werner B. F. Brouwer, Sang-Il Lee, Hye-Won Koo
Original Research Article
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma
Bernd Brüggenjürgen, Dagmar Selim, Peter Kardos, Kai Richter, Claus Vogelmeier, Stephanie Roll, Wolfgang Meyer-Sabellek, Roland Buhl, Stefan N. Willich
Original Research Article
Costs and medical care consequences associated with the diagnosis of peripheral arterial disease
Kristen Migliaccio-Walle, J. Jaime Caro, Khajak J. Ishak, Judith A. O’Brien
Correspondence
Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK
Eduardo Carracedo-Martínez
Correspondence
The authors’ reply
Andrew Moore, Ceri Phillips, Elke Hunsche, James Pellissier, Simone Crespi